- Approval Id
- d9548cedd7705e8a
- Drug Name
- BUFENCON INJECTION
- Product Name
- BUFENCON INJECTION
- Approval Number
- SIN07795P
- Approval Date
- 1994-07-15
- Registrant
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Licence Holder
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- INJECTION
- Dosage
- <p><strong><u>DOSAGE AND ADMINISTRATION:</u></strong><br>
<em>Intramuscular Injection:</em> 1.0mL repeated according to the response of the condition.</p>
<ol>
<li>Effective control of symptoms with 1.0–2.0 mL is obtained in bronchial asthma, hay fever, allergic bronchitis and allergic rhinitis. Onset of relief has occurred within a few hours of intramuscular injection.</li>
<li>In the treatment of acute or chronic bursitis, excellent results are obtained with intramuscular injection of 1.0–2.0 mL, repeated as necessary.</li>
</ol>
<p><em>Local administration:</em></p>
<ol>
<li>Intra-articular Injection:<br>
Large joints (knee, hip, shoulder): 1.0–2.0 mL<br>
Medium joints (below the wrist, ankle): 0.5–1.0 mL<br>
Small joints (foot, hand, chest): 0.25–0.5 mL</li>
<li>Intradermal Injection:<br>
For dermatologic conditions, 0.2 mL/cm<sup>2</sup> with a tuberculin syringe and a small 26-gauge needle is recommended. The total amount of Bufencon Injection injected at all sites each week should not exceed 1.0 mL.</li>
<li>Intralesional Injection:<br>
A tuberculin syringe with a small 25-gauge needle is suitable for most injections into the foot. Recommended doses at intervals of approximately one week: bursitis under heloma durum or molle, 0.25–0.5 mL; bursitis under calcaneal spur, 0.5 mL; bursitis over hallux rigidus, 0.5 mL; bursitis over digiti quinti varus, 0.5 mL; synovial cyst, 0.25–0.5 mL; Morton's neuralgia (metatarsalgia), 0.25–0.5 mL; tenosynovitis, 0.5 mL; periostitis of cuboid, 0.5 mL; acute gouty arthritis, 0.5–1.0 mL.<br>
To be administered only by a physician.</li>
</ol>
- Route Of Administration
- INTRAMUSCULAR, INTRADERMAL
- Indication Info
- <p><strong><u>INDICATIONS:</u></strong><br>
Musculoskeletal and soft tissue inflammatory conditions, allergic dermatologic conditions, and collagen diseases.</p>
- Contraindications
- <p><strong><u>CONTRAINDICATIONS:</u></strong><br>
As with other corticosteroid preparations, Bufencon Injection is contra-indicated in systemic infections.<br>
Corticosteroids should not be injected into unstable joints, infected areas, or intervertebral spaces.</p>
- Atc Code
- H02AB01
- Atc Item Name
- betamethasone
- Pharma Manufacturer Name
- YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
- Company Detail Path
- /organization/yung-shin-pharmaceutical-singapore-pte-ltd
